Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management in adults with obesity
These therapies have real potential to improve skin quality and support longevity
6 Gutierrez L, Folch A, Rojas M, Cantero JL, Atienza M, Folch J, Camins A, Ruiz A, Papandreou C, Bull M
These limitations underscore the need for large-scale randomized controlled trials with diverse patient populations and longer treatment durations to accurately assess the effects of GLP-1 RAs in the management of psoriasis
Together, they provide patients with a medically supervised, evidence-based approach to achieving safe and lasting weight loss